Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial
Phase: PHASE2 | Sponsor: University Health Network, Toronto | Compound: Psilocybin
- Status
- active
- Institution
- University Health Network, Toronto
- Start date
- 2024-06-06
- End date
- 2026-06-15
- Registry ID
- NCT06416085
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.